Lung Disease

Sept. 14 marks the second annual ILD Day, which aims to increase awareness of interstitial lung diseases.

Digital biomarkers derived from portable spirometers and smartwatches show promise as candidate endpoints for use in clinical trials or clinical care of pediatric asthma and cystic fibrosis, researchers reported.

Recurrent episodes of childhood bronchitis appear to be associated with increased risk for lung disease later in life, researchers reported in BMJ Open Respiratory Research.

Treatment with azithromycin from the time of diagnosis of cystic fibrosis in infancy did not reduce the extent of structural lung disease at age 36 months, but did reduce airway inflammation and morbidity, according to the COMBAT CF trial.

A new study quantified significant short-term within-day variability in blood eosinophil counts in patients with stable COPD.

Urinary VEGF levels were lower in premature infants with severe lung disease who developed chronic kidney disease compared with those who did not develop CKD, implying VEGF may be a biomarker of CKD in this patient population.

In this video, Jeffrey A. Sparks, MD, MMSc, discusses cluster-analysis data from ACR Convergence 2021, which investigated multimorbidity patterns among patients with rheumatoid arthritis.

Jeffrey A. Sparks, MD, MMSc, speaks with Healio about a presentation from ACR Convergence 2021 that reported predictors of mortality based on both rheumatoid arthritis and lung characteristics.

Reducing excess body fat and adjusting factors of metabolic syndrome can greatly lower the risk for lung disease among World Trade Center first responders, according to data in the American Journal of Respiratory and Critical Care Medicine.

The FDA granted Paratek Pharmaceuticals orphan drug designation for Nuzyra to treat infections caused by nontuberculous mycobacteria, the company announced this week.